Disclosures for "TDP-43 Cooperates With Nuclear Exosome Targeting Complex in Regulating SCARNA2 Metabolism"
-
Dr. Oshima has nothing to disclose.
-
Dr. Suzuki has nothing to disclose.
-
Mr. Abe has nothing to disclose.
-
Dr. Shintaro has nothing to disclose.
-
Mrs. Ike has nothing to disclose.
-
Dr. Yaguchi has nothing to disclose.
-
Dr. Takahashi has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Ono Pharamaceutical.
-
Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for DaiichiSankyo. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SumitomoPharma. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for KyowaKirin. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Japan. Dr. Yabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly Japan. The institution of Dr. Yabe has received research support from Toppan. The institution of Dr. Yabe has received research support from Ceres. The institution of Dr. Yabe has received research support from Hakuyo-Kai. The institution of Dr. Yabe has received research support from Choan-Kai.